US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers

Table 1 Clinicopathologic biomarkers of the 37 breast cancer patients

Pathologic biomarkers		Number
Menstrual status	Premenopause	16
Menstrual status	menopause	21
Histology	Invasive ductal carcinoma	31
	Invasive lobular carcinoma	1
	Invasive micropapillary carcinoma	3
	Poorly differentiated carcinoma	2
Tumor size	<2 cm	20
Tumor size	≥2 cm	17
Histologic grade	Low	16
Histologic grade	High	21
Estrogen receptor	Negative	15
Estrogen receptor	Positive	22
Progesterone receptor	Negative	13
Progesterone receptor	Positive	24
HER-2	Negative	31
HER-2	Positive	6
Triple-negative	Negative	27
Triple-negative	Positive	10
Ki-67	Low	18
Ki-67	High	19
Lymphovascular invasion	Negative	23
	Positive	3
	Not available	11
Lymph node metastasis	Negative	24
Lymph node metastasis	Positive	13

ISSN: 1471-2407